Impact and Feasibility of a Community Pharmacy Bone Mineral Density Screening and Education Program

American Association of Clinical Endocrinologists, 2001, 2001 Medical guidelines for clinical practice for the prevention and management of postmenopausal osteoporosis, Endocr Pract, 7, 293

Rosenthal, 2000, Implementing bone mineral density testing in the community pharmacy, J Am Pharm Assoc., 40, 737

Hans, 1996, Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study, Lancet., 348, 511, 10.1016/S0140-6736(95)11456-4

Thompson, 1998, Quantitative ultrasound (QUS) of the heel predicts wrist and osteoporosis-related fractures in women age 45–75 years, J Clin Densitometry., 1, 219, 10.1385/JCD:1:3:219

Greenspan, 1997, Precision and discriminatory ability of calcaneal bone assessment technologies, J Bone Miner Res., 12, 1303, 10.1359/jbmr.1997.12.8.1303

Schaefer, 1998, Increasing awareness of osteoporosis: a community pharmacy's experience, US Pharm., 72

Farina, 1999, Osteoporosis screening, US Pharm., 38

Product information. Lunar Achilles Express. Madison, Wis.: GE Lunar Corporation.

Elliot, 2002, Osteoporosis screening by community pharmacists: use of National Osteoporosis Foundation resources, J Am Pharm Assoc., 42, 101

Elliott, 2002, Pharmacy-based bone mass measurement to assess osteoporosis risk, Ann Pharmacother., 36, 571, 10.1345/aph.1A299

Zillich, 2001, Payment for pharmaceutical care?, J Am Pharm Assoc., 41, 4